Skip to content

Clinical trials

Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Clear all

3,654 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200053
200145
200260
200362
200483
2005100
2006113
2007107
2008140
2009112
2010136
2011116
2012133
2013106
2014133
2015138
2016129
2017145
2018145
2019168
2020141
2021191
2022192
2023188
2024169
2025163
2026185

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,686
Recruiting509
Terminated484
Unknown status345
Active, not recruiting294
Not yet recruiting144
Withdrawn135
No longer available20
Suspended16
Enrolling by invitation9
Available6
Approved for marketing6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)137
Celgene92
Mayo Clinic83
Memorial Sloan Kettering Cancer Center78
Fred Hutchinson Cancer Center71
M.D. Anderson Cancer Center67
Janssen Research & Development, LLC63
University of Arkansas55
Amgen42
GlaxoSmithKline40

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma3,654
Neoplasms, Plasma Cell521
Lymphoma, Non-Hodgkin467
Lymphoma463
Recurrence400
Leukemia, Lymphocytic, Chronic, B-Cell392
Hodgkin Disease390
Precursor Cell Lymphoblastic Leukemia-Lymphoma363
Leukemia, Myeloid, Acute348
Leukemia325

Trials

Showing 1 to 25 of 3,654. Each trial links to its page on Pharma Observatory.

3,554 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.